Inventor
LANE HEIDI ALEXANDRA
CH9 patents
⚠️ This page may combine multiple inventors who share the name “LANE HEIDI ALEXANDRA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LANE HEIDI ALEXANDRA
5 patentsUS10006078B2Jun 26, 2018
Use of phospho-Akt as a biomarker of drug response
LANE HEIDI ALEXANDRA2 citations70
US9995754B2Jun 12, 2018
Use of glu-tubulin as a biomarker of drug response to furazanobenzimidazoles
LANE HEIDI ALEXANDRA2 citations70
US9366682B2Jun 14, 2016
Use of stathmin as a biomarker of drug response to furazanobenzimidazoles
LANE HEIDI ALEXANDRA3 citations70
US9476889B2Oct 25, 2016
Use of acetylated tubulin as a biomarker of drug response to furazanobenzimidazoles
LANE HEIDI ALEXANDRA2 citations59
US10222377B2Mar 5, 2019
Use of BUBR1 as a biomarker of drug response to furazanobenzimidazoles
LANE HEIDI ALEXANDRA0 citations47
BASILEA PHARMACEUTICA AG
4 patentsUS10067120B2Sep 4, 2018
Use of acetylated tubulin as a biomarker of drug response to furazanobenzimidazoles
BASILEA PHARMACEUTICA AG2 citations71
US9970938B2May 15, 2018
Use of BUBR1 as a biomarker of drug response to furazanobenzimidazoles
BASILEA PHARMACEUTICA AG2 citations69
US10724072B2Jul 28, 2020
Use of phospho-Akt as a biomarker of drug response
BASILEA PHARMACEUTICA AG0 citations50
US10656162B2May 19, 2020
Use of glu-tubulin as a biomarker of drug response to furazanobenzimidazoles
BASILEA PHARMACEUTICA AG0 citations50